Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical practice and new technology: prostate-specific antigen (PSA).

M E Stuart1, M A Handley, R S Thompson

  • 1Group Health Cooperative of Puget Sound, Seattle, WA 98112.

HMO Practice
|November 4, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urban groundwater quality in sub-Saharan Africa: current status and implications for water security and public health.

Hydrogeology journal·2020
Same author

A method for screening groundwater vulnerability from subsurface hydrocarbon extraction practices.

Journal of environmental management·2019
Same author

Global patterns of nitrate storage in the vadose zone.

Nature communications·2017
Same author

Modification of Shape Memory Polymer Foams Using Tungsten, Aluminum Oxide, and Silicon Dioxide Nanoparticles.

RSC advances·2016
Same author

Hydrochemical profiles in urban groundwater systems: New insights into contaminant sources and pathways in the subsurface from legacy and emerging contaminants.

The Science of the total environment·2016
Same author

Macronutrient status of UK groundwater: Nitrogen, phosphorus and organic carbon.

The Science of the total environment·2016

Prostate specific antigen (PSA) screening for prostate cancer did not meet Group Health Cooperative criteria. Educational programs and practice changes were implemented to manage PSA test use and outcomes.

Area of Science:

  • Urology
  • Health Services Research

Background:

  • Increased utilization of prostate specific antigen (PSA) testing for prostate cancer screening.
  • Need for evaluation of screening test appropriateness within a healthcare system.

Purpose of the Study:

  • To evaluate the appropriateness of PSA as a prostate cancer screening test based on established criteria.
  • To describe the development and implementation of a program to manage PSA test utilization.

Main Methods:

  • Literature review to assess PSA against GHC's screening criteria.
  • Development of a comprehensive program including staff education, practice change facilitation, outcome measurement, and physician feedback.

Main Results:

  • Prostate specific antigen (PSA) did not meet the established criteria for screening.

Related Experiment Videos

  • A multi-faceted program was designed and implemented to address PSA test use.

    • Conclusions:

    • The evaluation determined PSA was not suitable for routine screening at GHC.
    • A structured program was developed to guide the appropriate use of PSA testing and monitor outcomes.